Clinical Trial Update: The Effects of a Commercially Available Synbiotic on the Gut Microbiome and Cardiometabolic Health: A Randomized Double-Blind Placebo-Controlled Trial [NA]

View source ↗

Summary

A randomized double-blind, placebo-controlled trial evaluated the effects of a commercially available synbiotic on gut microbiome and cardiometabolic health in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• Commercially available synbiotic product (unspecified synbiotic)

Snippet

Sponsor: Southern Utah University | Conditions: Hypertension, Gut Dysbiosis | NA | Status: COMPLETED